Last year, England’s then-chief medical officer Dame Sally Davies called for controversial Extinction Rebellion-style campaigns on the issue of antibiotic resistance, saying it was vital to raise awareness.
A government official calling for civil disobedience is highly unusual, but Dame Sally said the consequences of antibiotic resistance posed at least as great a threat to humanity’s future as climate change, and in the same timescale, but few efforts had been made to deal with the issue.
Dame Sally is now the UK’s Special Envoy on Antimicrobial Resistance (AMR) and at last month’s Davos she launched the ‘Investor Year of Action on AMR’.
Aviva, one of the first investors to join the initiative, credits Dame Sally for drawing its attention to the issue.
Abigail Herron, Aviva’s Global Head of Responsible Investment, tells RI that the investor’s interest was initially piqued by a 2015 BBC documentary: Panorama – Antibiotic Apocalypse. “One in…